77181-69-2 | 1-β-D-Arabinofuranosyl-5-[(1E)-2-bromoethenyl]-2,4(1H,3H)-pyrimidinedione

Packsize	Purity	Availability	Price	Discounted Price
10mg	99%	in stock	$236.00	$165.00
25mg	99%	in stock	$470.00	$329.00
50mg	99%	in stock	$799.00	$559.00
100mg	99%	in stock	$1,356.00	$949.00

Description

• Catalog Number: AB53444
• Chemical Name: 1-β-D-Arabinofuranosyl-5-[(1E)-2-bromoethenyl]-2,4(1H,3H)-pyrimidinedione
• CAS Number: 77181-69-2
• Molecular Formula: C11H13BrN2O6
• Molecular Weight: 349.1347
• MDL Number: MFCD00866949
• SMILES: Br/C=C/c1cn(c(=O)[nH]c1=O)[C@@H]1O[C@@H]([C@H]([C@@H]1O)O)CO

Computed Properties

• Complexity: 480
• Covalently-Bonded Unit Count: 1
• Defined Atom Stereocenter Count: 4
• Defined Bond Stereocenter Count: 1
• Heavy Atom Count: 20
• Hydrogen Bond Acceptor Count: 6
• Hydrogen Bond Donor Count: 4
• Rotatable Bond Count: 3
• XLogP3: -0.9

Literature

• 3'-[4-Aryl-(1,2,3-triazol-1-yl)]-3'-deoxythymidine analogues as potent and selective inhibitors of human mitochondrial thymidine kinase.

  Journal of medicinal chemistry 20100408

• 5-alkynyl analogs of arabinouridine and 2'-deoxyuridine: cytostatic activity against herpes simplex virus and varicella-zoster thymidine kinase gene-transfected cells.

  Journal of medicinal chemistry 20070614

• Novel selective human mitochondrial kinase inhibitors: design, synthesis and enzymatic activity.

  Bioorganic & medicinal chemistry 20070415

• Susceptibilities of several clinical varicella-zoster virus (VZV) isolates and drug-resistant VZV strains to bicyclic furano pyrimidine nucleosides.

  Antimicrobial agents and chemotherapy 20050301

• Synthesis and antiviral activities of 1'-carbon-substituted 4'-thiothymidines.

  Bioorganic & medicinal chemistry 20041015

• Inactivity of the bicyclic pyrimidine nucleoside analogues against simian varicella virus (SVV) does not correlate with their substrate activity for SVV-encoded thymidine kinase.

  Biochemical and biophysical research communications 20040319

• In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?

  Antiviral research 20040301

• Drug interaction ontology (DIO) for inferences of possible drug-drug interactions.

  Studies in health technology and informatics 20040101

• In vitro activity of potential anti-poxvirus agents.

  Antiviral research 20030101

• [Molecular toxicological mechanism of the lethal interactions of the new antiviral drug, sorivudine, with 5-fluorouracil prodrugs and genetic deficiency of dihydropyrimidine dehydrogenase].

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20020801

• Design, synthesis and enzymatic activity of highly selective human mitochondrial thymidine kinase inhibitors.

  Bioorganic & medicinal chemistry letters 20010521

• 2'-O-Acyl/alkyl-substituted arabinosyl nucleosides as inhibitors of human mitochondrial thymidine kinase.

  Biochemical pharmacology 20010315

• Recent developments in herpesvirus therapy.

  Herpes : the journal of the IHMF 20010301

• Effects of light intensity, n-alcohols, water-soluble colorants, and solution viscosity on photoisomerization of sorivudine.

  Pharmaceutical development and technology 20010101

• Selective activity of various antiviral compounds against HHV-7 infection.

  Antiviral research 19990801

• Synthesis of novel 4'-C-methyl-pyrimidine nucleosides and their biological activities.

  Bioorganic & medicinal chemistry letters 19990322

• Anti-herpesvirus activity profile of 4'-thioarabinofuranosyl purine and uracil nucleosides and activity of 1-beta-D-2'-fluoro-4'-thioarabinofuranosyl guanine and 2,6-diaminopurine against clinical isolates of human cytomegalovirus.

  Antiviral research 19980801

• Structure-activity relationship of the affinity of 5-substituted uracil nucleoside analogues for varicella-zoster virus thymidine kinase and their activity against varicella-zoster virus.

  Antiviral research 19970801

• A facile, alternative synthesis of 4'-thioarabinonucleosides and their biological activities.

  Journal of medicinal chemistry 19970704

• Analysis of phosphorylation pathways of antiherpesvirus nucleosides by varicella-zoster virus-specific enzymes.

  Antimicrobial agents and chemotherapy 19960401

• Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6.

  Antiviral research 19951201

• Comparative activity of selected antiviral compounds against clinical isolates of varicella-zoster virus.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 19950401

• Synthesis and antiviral activity of 1-cyclobutyl-5-(2-bromovinyl)uracil nucleoside analogues and related compounds.

  Journal of medicinal chemistry 19920515

• Inhibition of human herpesvirus 6 replication by 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (2HM-HBG) and other antiviral compounds.

  Antimicrobial agents and chemotherapy 19901201

• Effect of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil against herpes simplex virus type 1 infection in immunosuppressed mice.

  Antimicrobial agents and chemotherapy 19901201

• Comparative activities of several nucleoside analogs against duck hepatitis B virus in vitro.

  Antimicrobial agents and chemotherapy 19900701

• Effect of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (brovavir) on experimental infections in mice with herpes simplex virus type 1 strains of different degrees of virulence.

  Antimicrobial agents and chemotherapy 19900501

• (E)-5-(2-bromovinyl)uridine requires phosphorylation by the herpes simplex virus (type 1)-induced thymidine kinase to express its antiviral activity.

  Biochemical pharmacology 19890615

• Effects of various nucleosides on antiviral activity and metabolism of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil against herpes simplex virus types 1 and 2.

  Antimicrobial agents and chemotherapy 19881001

• Efficacies of antiherpesvirus nucleosides against two strains of herpes simplex virus type 1 in Vero and human embryo lung fibroblast cells.

  Antimicrobial agents and chemotherapy 19880701

• Comparison of two bromovinyl nucleoside analogs, 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil and E-5-(2-bromovinyl)-2'-deoxyuridine, with acyclovir in inhibition of Epstein-Barr virus replication.

  Antimicrobial agents and chemotherapy 19880701

• Comparison of susceptibilities of varicella-zoster virus and herpes simplex viruses to nucleoside analogs.

  Antimicrobial agents and chemotherapy 19860301

• In vitro and in vivo antiviral activity of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (BV-araU) and related compounds.

  Antiviral research 19840601

• Strains of varicella-zoster virus resistant to 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil.

  Antimicrobial agents and chemotherapy 19840601

• Antiherpes activity of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil and some other 5-substituted uracil arabinosyl nucleosides in two different cell lines.

  Antiviral research 19830901

• Inhibitory effect of E-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil on herpes simplex virus replication and DNA synthesis.

  Journal of virology 19820701

• Inhibitory effects of antiherpesviral thymidine analogs against varicella-zoster virus.

  Antimicrobial agents and chemotherapy 19820201

• Antiherpes activity of [E]-5-(1-propenyl)-2'-deoxyuridine and 5-(1-propenyl)-1-beta-D-arabinofuranosyluracil.

  Antiviral research 19811101

• Differential activity of potential antiviral nucleoside analogs on herpes simplex virus-induced and human cellular thymidine kinases.

  Antimicrobial agents and chemotherapy 19810901

• Antiherpesviral and anticellular effects of 1-beta-D-arabinofuranosyl-E-5-(2-halogenovinyl) uracils.

  Antimicrobial agents and chemotherapy 19810701